JMIR (Journal of Medical Internet Research) and its editorial board lack basic academic ethics and may engage in aggressive marketing and fraudulent fast track fee practices.

This year, after submitting a work from our team to JMIR, the journal issued an E2 Reject after the first major revision and the second minor revision, citing “Low Impact” as the reason, which is absurd. We appealed this decision, but the editorial board’s responses were contradictory, accusing our methodology of flaws that were not pointed out in the previous two rounds of revisions.

On Chinese social media, many people have reported that the journal engages in fraudulent fast track fee practices and forced transfers (with violent rejections if not agreed). After experiencing this series of submission processes this year, I question the professionalism and rigor of this series of journals and recommend researchers to be cautious when submitting to this series of journals.